Low LDL-Cholesterol and Hemorrhagic Risk: Mechanistic Insights and Clinical Perspectives

Area of Science:

• Cardiovascular Medicine
• Lipid Metabolism
• Hemostasis and Thrombosis

Background:

• Low-density lipoprotein cholesterol (LDL-C) is a key target for preventing atherosclerotic cardiovascular diseases (CVDs).
• Recent strategies aim for ultra-low LDL-C levels (<55 mg/dL or <30 mg/dL) in high-risk patients.
• While LDL-C reduction prevents heart attack and stroke, concerns exist about increased bleeding risk at very low levels.

Purpose of the Study:

• To critically examine the molecular mechanisms linking reduced LDL-C to hemostatic system alterations.
• To explore the impact of low cholesterol on platelet function, endothelial integrity, and coagulation.
• To assess evidence for the association between very low LDL-C and bleeding events.

Main Methods:

• Review of molecular mechanisms of cholesterol's role in hemostasis.
• Analysis of experimental and clinical studies on LDL-C and bleeding risk.
• Exploration of the interplay between cholesterol, platelets, endothelium, and coagulation.

Main Results:

• Emerging evidence suggests a potential association between very low LDL-C and increased bleeding, particularly hemorrhagic stroke and gastrointestinal hemorrhage.
• Molecular mechanisms involve the complex influence of cholesterol availability on platelet function, endothelial barrier stability, and coagulation pathways.
• Understanding this paradoxical risk is crucial for balancing lipid-lowering benefits with potential bleeding complications.

Conclusions:

• Very low LDL-C levels, while beneficial for preventing ischemic events, may paradoxically increase bleeding risks.
• Further research into the biological basis of this association is essential for personalized and safe cardiovascular prevention strategies.
• A balanced approach is needed to optimize lipid management, considering both thrombotic and bleeding risks.